Sign in
4

Changes in Ownership

RxSight, Inc. Filed Acc 0001209191-23-060012

President & CEO sold 22,500 shares at $41.09 ($924,498)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Kurtz Ronald M MD President & CEO 2023-12-27 Sale 10b5-1 −22,500 $41.09 $924,498 867,110 I
Open-market sales · 22,500 sh · avg $41.09 · $924,498
Loading xslF345X05/doc4.xml…